Post-kala-azar dermal leishmaniasis (PKDL) is usually a sequel of visceral leishmaniasis and is one of the skin neglected tropical diseases. It occurs mainly in East Africa and on the Indian subcontinent, where 5–10% of patients with kala-azar are reported to develop the condition. People with PKDL are considered a potential source of Leishmania infection.
Post-kala-azar dermal leishmaniasis (PKDL) is considered a potential source of Leishmania infection in the community. It presents as a sequela of visceral leishmaniasis in areas endemic for L. donovani. Therefore it acts as an important link in the control and elimination of visceral leishmaniasis.
By the end of this course, you should be able to:
Understand the importance of PKDL, clinically and in control of visceral leishmaniasis (VL)
Explain the epidemiology and geographical differences
Describe the clinical aspects of PKDL
Adequately diagnose PKDL using available tools
Describe when and how to start treatment if needed
Describe surveillance, monitoring, and evaluation for PKDL
